Unknown

Dataset Information

Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review.


ABSTRACT:

Purpose

Older people are at risk of anticholinergic side effects due to changes affecting drug elimination and higher sensitivity to drug's side effects. Anticholinergic burden scales (ABS) were developed to quantify the anticholinergic drug burden (ADB). We aim to identify all published ABS, to compare them systematically and to evaluate their associations with clinical outcomes.

Methods

We conducted a literature search in MEDLINE and EMBASE to identify all published ABS and a Web of Science citation (WoS) analysis to track validation studies implying clinical outcomes. Quality of the ABS was assessed using an adapted AGREE II tool. For the validation studies, we used the Newcastle-Ottawa Scale and the Cochrane tool Rob2.0. The validation studies were categorized into six e

SUBMITTER: Lisibach A 

PROVIDER: S-EPMC7803697 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature